EHI
AGIO icon

Eagle Health Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Eagle Health Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-246,230
Closed -$9.88M – 31
2025
Q3 		$9.88M Sell
246,230
-84,600
-26% -$3.18M 2.59% 16
2025
Q2 		$11M Hold
330,830
– – 2.72% 17
2025
Q1 		$9.69M Hold
330,830
– – 2.52% 14
2024
Q4 		$10.9M Hold
330,830
– – 2.67% 13
2024
Q3 		$14.7M Hold
330,830
– – 2.78% 16
2024
Q2 		$14.3M Hold
330,830
– – 2.5% 18
2024
Q1 		$9.67M Hold
330,830
– – 1.8% 19
2023
Q4 		$7.37M Buy
330,830
+63,200
+24% +$1.42M 1.5% 17
2023
Q3 		$6.62M Hold
267,630
– – 1.46% 17
2023
Q2 		$7.58M Hold
267,630
– – 1.42% 22
2023
Q1 		$6.15M Hold
267,630
– – 1.2% 20
2022
Q4 		$7.52M Sell
267,630
-62,083
-19% -$1.75M 1.73% 16
2022
Q3 		$9.32M Sell
329,713
-246,700
-43% -$6.62M 2.14% 17
2022
Q2 		$12.8M Buy
576,413
+145,000
+34% +$3.28M 2.98% 17
2022
Q1 		$12.6M Hold
431,413
– – 3.09% 17
2021
Q4 		$14.2M Buy
431,413
+195,900
+83% +$7.89M 3.46% 16
2021
Q3 		$10.9M Hold
235,513
– – 3.45% 15
2021
Q2 		$13M Sell
235,513
-119,137
-34% -$6.66M 4.45% 11
2021
Q1 		$18.3M Buy
354,650
+284,950
+409% +$14.1M 7.19% 4
2020
Q4 		$3.02M Buy
+69,700
New +$2.76M 1.93% 18

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Eagle Health Investments's AGIO Position: Q4 2025 in Review

Eagle Health Investments sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 246,230 shares — an estimated $9.88M sold.

Eagle Health Investments first reported a position in AGIO in Q4 2020 and held it in 20 quarters. The position peaked at $18.3M in Q1 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Eagle Health Investments reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Eagle Health Investments sold 246,230 Agios Pharmaceuticals shares in Q4 2025, an estimated $9.88M.
  • Eagle Health Investments first reported a position in Agios Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Eagle Health Investments's Agios Pharmaceuticals position peaked at $18.3M in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Eagle Health Investments's 13F filing for Q4 2025, filed 6 Feb 2026.